Fig. 3
From: SOX11 is a sensitive and specific marker for pulmonary high-grade neuroendocrine tumors
The overall survival of small cell lung carcinomas (SCLCs), large cell neuroendocrine carcinomas (LCNECs) and high-grade neuroendocrine carcinomas (HG-NECs) between SOX11 positive and negative cases. Kaplan-Meier survival curve showing that SOX11 exhibit no impact on SCLCs, LCNECs and HG-NECs patient survival (A, B and C, p = 0.2961, 0.6399 and 0.3968, respectively)